title: [Subclinical hypothyroidism as a cause of dyslipidemia].
abstract: Subclinical hypothyroidism (SHT) is a clinical-laboratory syndrome characterized by an elevated thyrotropin level and normal levels of T3 and T4. Lipid metabolism disorders in patients with SHT and the influence of substitution therapy with L-thyroxin on the lipid profile are considered in many publications, but the results of these studies are contradictory. This paper was aimed to discuss the relevant literature and search for the most effective treatment strategy.
authors.forename: A V
authors.initials: AV
authors.lastname: Budnevsky
authors.forename: A Ya
authors.initials: AY
authors.lastname: Kravchenko
authors.forename: E S
authors.initials: ES
authors.lastname: Drobysheva
authors.forename: A A
authors.initials: AA
authors.lastname: Fes'kova
mesh_terms: D050171:Dyslipidemias / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D007037:Hypothyroidism / Q000150:complications*; D013974:Thyroxine / Q000627:therapeutic use*
chemical_list: D013974:Thyroxine